Serial Number | 97544808 |
Word Mark | EXUMA |
Filing Date | Thursday, August 11, 2022 |
Status | 730 - FIRST EXTENSION - GRANTED |
Status Date | Wednesday, November 6, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 12, 2024 |
Goods and Services | Custom manufacturing of medical products in the nature of biological tissue, blood, viruses, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy, including gene therapy, CAR T cell therapy, and cell therapy; custom manufacturing of biological preparations for the treatment of cancer |
Goods and Services | Medicines for human purposes in the nature of pharmaceutical preparations for gene and cell therapy, immunotherapy and the treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, and infectious diseases; biological preparations for medical treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, gene and cell therapy, and infectious diseases for humans and animals; medical biological tissue cultures and viruses for the prevention and treatment of cancer for humans and animals; drug products in the nature of pharmaceutical preparations for immunotherapy and the treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, and infectious diseases for humans and animals |
Goods and Services | Bacteriological research; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research; virological research; medical laboratory services; scientific research; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs, namely, processing blood to isolate leukocytes for the creation of immunotherapies; scientific and medical research and development of pharmaceutical preparations and drugs; computer programming in relation to medicine and medical research; research in the field of stem cells |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 31, 2022 |
Primary Code | 040 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 31, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 31, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Exuma Biotech Corp. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | West Palm Beach, FL 33401 |
Party Name | Exuma Biotech Corp. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | West Palm Beach, FL 33401 |
Event Date | Event Description |
Monday, August 15, 2022 | NEW APPLICATION ENTERED |
Wednesday, August 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, May 31, 2023 | ASSIGNED TO EXAMINER |
Friday, June 2, 2023 | NON-FINAL ACTION WRITTEN |
Friday, June 2, 2023 | NON-FINAL ACTION E-MAILED |
Friday, June 2, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, September 1, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Friday, September 1, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Monday, December 4, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, December 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, December 5, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, December 6, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, December 6, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, December 6, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, December 6, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Wednesday, January 3, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, January 16, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Monday, February 5, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Monday, February 5, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Monday, February 5, 2024 | EXAMINERS AMENDMENT E-MAILED |
Monday, February 5, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, February 5, 2024 | EXAMINER'S AMENDMENT ENTERED |
Monday, February 5, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 7, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Wednesday, November 6, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, November 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, November 6, 2024 | SOU EXTENSION 1 GRANTED |
Wednesday, November 6, 2024 | SOU EXTENSION 1 FILED |